Dr. Vishal Rao, an oncologist and head and neck surgeon at the Bangalore-based HealthCare Global (HCG) Cancer Center, writes about the debate on food safety in India and how it is related to cancer. A 45-year-old man presented himself to an oncologist with the typical symptoms of stomach cancer. His worst fears came true, the…Read more I Don’t #Smoke or #Drink, I Eat Well & #Exercise. How Did I Still Get #Cancer? An #Oncologist Answers.
Washington D.C [USA], Mar. 18: A breakthrough 'gene silencer' drug has the power to 'switch off' heart disease by reducing cholesterol by over 50 percent. The findings come from the largest trial yet to test the safety and effectiveness of this kind of therapy. The technique, known as RNA interference (RNAi) therapy, essentially 'switches off' one of the genes…Read more New ‘gene silencer’ #cholesterol #drug can ‘switch off’ heart #disease
Taro Pharmaceuticals Inc (Canada) has entered into an agreement to acquire all of the issued and outstanding shares of Thallion Pharmaceuticals, a Canadian pharmaceutical corporation, Sun Pharma said in a regulatory filing. Sun Pharmaceuticals Industry today said an indirect arm of its group firm Taro will fully acquire Canada's Thallion Pharmaceuticals for 2.7 million Canadian…Read more #SunPharma indirect arm to acquire #Thallion Pharmaceuticals
India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries. India supplies nearly a third of medicines sold in the United States, the world's largest healthcare market. Cut-price…Read more Domestic #drugmakers face squeeze in #US healthcare market
Researchers at Cardiff University have devised a new way of creating a drug commonly used as the first line of defence against malaria around the world. Artemisinin is a drug recommended by the World Health Organisation for treatment of all cases of severe malaria and works by attacking all stages of the malaria parasite in…Read more New method for producing leading #antimalarial drug
Drug pricing regulator NPPA has received Rs 672.28 crore fine till date from pharmaceutical companies for overcharging, Parliament was informed today. Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging on sales of formulations at prices above the notified ceiling price. "Demand notices have been issued for…Read more Indian Govt gets Rs 672 cr fine from pharma cos for overcharging